Treat-to-target approach in the management of inflammatory Bowel disease

Pharmacology, Toxicology and Pharmaceutical Science

• Inflammatory Bowel Disease 100%
• Biological Marker 50%
• Disease Exacerbation 50%
• Remission 50%
• Randomized Controlled Trial 50%
• Biological Product 50%
• Calgranulin 50%
• Intestine Injury 50%
• Diseases 50%

Medicine and Dentistry

• Inflammatory Bowel Disease 100%
• Quality of Life 50%
• Biological Marker 50%
• Randomized Controlled Trial 50%
• Disease Exacerbation 50%
• Biological Product 50%
• Faecal Calprotectin 50%
• Intestine Injury 50%
• Diseases 50%

Keyphrases

• Control Target 50%